Body Contouring Market Outlook Overview, Trends,Share and Forecast by 2032

Market Analysis

The global body contouring market research share is predicted to grow at a 14.0% CAGR over the forecast period (2023-2032), as per the latest Market Research Future (MRFR) report. Body contouring, which is also known as body sculpting, is a surgical procedure which improves the appearance of tissue and skin after a considerable weight loss. This procedure can include liposuction, breast lift, tummy tuck, or body lift. An average body contouring session will last about an hour but has no downtime. It has gained immense popularity as people are looking for safer, cost-effective, and less painful alternatives for getting the desired body shape.

Body contouring can be done both surgically and non-surgically, and both are gaining ample recognition. Although this procedure can address any part of the body but some of the most common areas which people seek to improve include calves, thighs, waistline and back, abdomen, breasts, upper arms, and face and neck.

Various factors are propelling in the body contouring market. These factors, as stated by the MRFR report, include increasing obese population, lack of exercise, diseases such as diabetes and cardiovascular ailments, adoption of fast food, and rising awareness and accessibility of cosmetic surgeries. Additional factors boosting market growth include advancements in technology, rising disposable income, demand for improved fat reduction procedures, presence of sophisticated infrastructure, expanding medical tourism industry, and growing urbanization. Besides, the different benefits that body contouring offers such as faster recovery time, minimal invasion, accurate fat measurement and removal, less trauma, and targeted internal delivery are also boosting the market growth.

On the contrary, the high cost of therapy may hinder the body contouring market trends growth over the forecast period.

 Key Players

the body contouring market players report include Wells Johnson Company (US), Erchonia (US), Invasix Aesthetic Solutions (US), InMode (US), Human Med (Germany), Chromogenex (UK), GlobalMed Technologies (US), Fotona (Slovenia), Cutera (US), BTL Industries (US), Andrew Technologies (Canada), Asclepion Laser Technologies (Germany), Valeant (Canada), Palomar Medical Technologies (US), Lumenis (Israel), Syneron Medical (Israel), Cynosure (US), Meridian (Michigan), and Alma Lasers (Israel).

July 2019: A new body-contouring device, CoolTone has received FDA clearance to firm up muscles in the thigs, butt, and the abs.

Market Segmentation

The Market Research Future report provides a wide segmental analysis of the body contouring market based on type.

Based on type, the body contouring marke is segmented into non-invasive and minimally invasive devices. The non-invasive devices segment is again segmented into high intensity focused ultrasound lipoplasty devices and radio frequency lipoplasty devices. The minimally invasive devices segment is again segmented into radio frequency assisted liposuction devices and laser-assisted lipolysis devices. Of these, the non-invasive segment will have the largest share in the market over the forecast period. This is owing to heavy investments being made by leading companies for developing advanced equipment and technologies. Moreover, its alluring features such as cost-effectiveness, short downtimes, and enhanced safety are also boosting the market growth.

Regional Analysis

Based on the region, the body contouring market report covers growth opportunities and the latest trends across the Asia Pacific (APAC), Europe, North America, and the Middle East and Africa (MEA). Of these, North America will spearhead the market over the forecast period. This is owing to 55% of the population in this region is suffering from obesity. Besides, governmental support for R&D activities for various surgery and devices and rising healthcare expenditure are also pushing market growth.

The body contouring market in Europe is predicted to have the second-largest share in the market over the forecast period.

The body contouring market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to increasing consumer disposable income, the presence of a huge target population, and the introduction of advanced products. Moreover, the growing demand for better devices and treatment and the rising prevalence of obesity and diabetes are pushing market growth. India, South Korea, Japan, and China are the key contributors in this region.

The body contouring market in the Middle East and Africa is predicted to have steady growth over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Fluoroscopy and Mobile C-Arms Market Outlook: Global Industry Share, Growth, Drivers, Emerging Technologies, and Forecast

Market Overview

Fluoroscopy can be defined as an imaging technique, which uses X-Ray technology for taking real-time images of the body. It allows the physicians to visualize muscles, organs, and bones, which further helps them to make crucial decisions during surgery. Fluoroscopy and Mobile C-Arms Market ShareSize is anticipated to reach USD 4.32 Billion by 2032 at 4.7% CAGR during the forecast period 2023-2032.

Factors like the rising incidence of chronic diseases, ever-increasing geriatric population, and high adoption of fluoroscopy in neurological and orthopedic procedures will supplement the market growth in the segment. Improving healthcare infrastructure, advancing technology in fluoroscopy and C-arms equipment, and increasing number of interventional radiology surgeries are likely to elevate the scope for the market across the globe. Moreover, rapid product launches and rising number of mergers and acquisitions will further contribute to the market growth in the long run. The shift towards a value-based healthcare model, surging adoption of minimally invasive surgeries, and soaring demand for improved imaging technology are likely to promote the market growth in the coming years.

On the contrary, the high cost of fluoroscopic and mobile c-arm systems, coupled with the risk of radiation exposure are some of the key concerns likely to restrict the market growth across the globe.

Fluoroscopy and Mobile C-Arms Market Outlook and Report Analysis By Device Type (Fluoroscopy Systems & Mobile C-Arms), Application (Gastrointestinal, Orthopedics, Neurology, & Others), End User (Hospital & Clinics & Others), Region - Forecast till 2030

 

Competitive Dashboard

The top operating in the Fluoroscopy and Mobile C-Arms Market Players scope include Canon Medical Systems Corporation (Japan), Allengers Medical Systems (India), GE Healthcare (US), DMS Group (France), Hologic Inc. (US), Hitachi Ltd (Tokyo), OrthoScan, Inc. (the US), Omega Medical Imaging, LLC (US), Shimadzu Corporation (Japan), Koninklijke Philips N.V. (The Netherlands), Varian Medical Systems, Inc. (US), Siemens (Germany), Ziehm Imaging GmbH (US), and Villa Sistemi Medicali Spa (Italy).

Global Fluoroscopy and Mobile C-Arms Market: Segmental Analysis

The Fluoroscopy and Mobile C-Arms Market analysis has been segmented on the basis of application, device type, and end user.

·         By device type, the market is segmented into fluoroscopy systems and mobile c-arms. Of these, the mobile C-arms segment will gain significant prominence, mainly due to the soaring incidence of cardiovascular disease and the rising number of orthopedic surgeries. C-arms are extensively used for surgeries of cardiovascular diseases, gastroenterology, neurosurgeries, traumatology, orthopedics, and urology disorders.

·         The market finds application in orthopedics, gastrointestinal, cardiovascular, pain management and trauma, urology, neurology, and others. Of these, the cardiovascular application will gain prominence due to the increased burden of cardiovascular diseases and better results offered by fluoroscopy systems during treatment and diagnosis.

·         Based on the end users, the market constitutes diagnostic centers, hospital and clinics, research and academic institutes, and others. Of these, the hospital and clinics segment accounted for USD 895.96 million in 2017. The high adoption of advanced and sophisticated imaging systems will drive the market growth in the segment.

Regional Frontiers

Geographically, the Fluoroscopy and Mobile C-Arms Market Outlook have been studied under regions namely, Europe, the Americas, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the Americas is predicted to acquire the lion’s share and dominate the market globally. In this region, North America is predicted to command the largest share, mainly due to the acceptance of innovative and latest products. Also, the surging awareness regarding medical imaging devices and rising financial capability to purchase expensive machines are driving the market growth in the region.

Europe is likely to register moderate growth in the foreseeable future. The regional growth can be credited to the surging prevalence of road accidents, which leads to orthopedic surgeries. The rising expenditure in the healthcare sector and increasing R&D activities will further contribute to the market growth in the long run.

Meanwhile, the Asia Pacific will register the fastest growth across the globe. Developing countries like India, China, and South Korea are gradually becoming major destinations for pathology testing and outsourcing clinical trials. This is likely to elevate the scope of the market in the region. The presence of untapped opportunities, surging awareness about medical imaging techniques and applications, and improving healthcare infrastructure are encouraging the regional market’s growth.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Syringe and Needle Market Size : A Global Analysis of the Market Trends

Market Overview-

The global syringe and needle market size is expected to grow USD 14.74 billion by 2032 at a CAGR of 5.90% and surpass its previous revenues over the forecast period of 2023–2032, as per a research report published by Market Research Future (MRFR). The syringe and needle market is growing primarily on account of a large pool of patients who augment the demand for needle and syringe. High prevalence of blood-borne diseases leads to a surge in the application of syringes and needles which fuels the market growth. The global geriatric population is increasing and contributing significantly to the market growth. This demographic is at high risk for chronic diseases, and the natural aging process weakens the body leading to increased overall medical visits. Increased demand for hypodermic needles which prevent the risk of needle-stick injuries also aids the growth of the market. Implementation of vaccination programs for diseases such as hepatitis, polio, rubella, tetanus, etc., also induces demand for needles and syringes which help in market expansion. Increase in a number of injectable drugs approved by the FDA also propels the market for syringes and needles. However, the growth of the market might be hindered by the risk associated with re-use and sharing of needles and syringes. Reuse of needles exposes consumers to the risk of acquiring diseases such as HIV and hepatitis C which is a major setback and constrain to the market growth. Risk of needlestick injuries and availability of alternatives also hinders the growth of the market. The market growth might be threatened by the introduction of needleless alternatives to meet the demands of a minimally invasive medical procedures.

Competitive Landscape

Global Syringe and Needle Market Players include

• Braun Medical Inc.,
• Terumo Corporation,
• Albert David Ltd,
• Covidien Plc,
• Smiths Medical, and
• Connecticut Hypodermics Inc.

Segmentation

The global syringes and needle market insights has been segmented based on type, therapeutic application, usability, and end-user. By type, the market has been segmented into Blood Collection, Intravenous, and Catheter. By therapeutic application, the market has been segmented into General Surgery and Diagnostic. By usability, the market has been segmented into disposable and reusable. By end user, the market has been segmented into Hospitals & Clinics and Home Care.

Regional Analysis

The key markets of the global syringes and needle market include North America, Europe, Asia Pacific and the Middle East & Africa. North America accounts for the majority share of the global market owing to the prevalence of chronic diseases in the region coupled with increased R&D activities which induce the demand of the market. Additionally, the presence of a large customer base in the region also propels the market growth. Europe is the second largest market owing to increased R&D spending by pharmaceuticals and biotechnology sector in the region. Presence of a developed healthcare sector also supports the market growth in the region. Asia Pacific is expected to be the fastest growing market over the forecast period. The growth in the region would be favored by the prevalence of chronic diseases in the region which escalates the need for treatment and growing research and development in the field of life sciences in the region.  The Middle East & Africa region is expected to exhibit the least growth over the forecast period due to less expenditure on healthcare and limited growth of the healthcare sector in the region.

Industry Updates

An American pharmacy, Sunrise Pharmacy is reportedly accepting discarded needles found in public spaces for a reward of 5 cents per used needle. The move is an attempt to solve the issue of discarded drug paraphernalia. 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Blood Coagulants Market Size, Insights, Application & Growth Drivers

Market Overview:

Blood coagulant aids in improving the coagulation process of blood in order to stop bleeding and fastening the healing process. According to the report that has been published by Market Research Future (MRFR), blood coagulants market insights is expected to reach USD 2.57 billion by 2030 at CAGR 10.90% during the forecast period 2022-2030

Competitive Landscape:

Increasing demand for high-quality blood coagulants in the market has led to the introduction of innovative products by the in the Middle East and Africa blood coagulants market players. The players are focusing on business expansion by increasing their research and development expenditure and strategizing mergers and acquisitions for establishing their products not on in the Middle East and Africa region but also on a global level.

In February 2018, it was announced that an Israeli-developed bandage named WoundClot, a plant-based gauze that stops blood loss within seconds by stimulating body’s coagulation process, will be sold globally.

The prominent players that are profiled in the report on the Middle East and Africa market by MRFR are

Pfizer Inc. (the U.S.),

Bayer AG (Germany),

Novo Nordisk AS (Denmark),

Shire (Republic of Ireland),

SOBI (Sweden),

Octapharma (Switzerland), and

CSL Limited (Australia).  Are Blood coagulants market players

Market Segmentation:

The Middle East and Africa blood coagulants market trends is segmented on the basis of types, indications, and by country. Based on types, the blood coagulants market is segmented into coagulation factor and others. Coagulation factor segment is sub-segmented into recombinant coagulation factor, plasma coagulation factor, and others.

Based on indication, the blood coagulants market is segmented into hemophilia, surgery, other bleeding disorders, and others. Hemophilia segment is sub-segmented into hemophilia A and hemophilia B.

Market Drivers and Restraints:

Increasing prevalence of bleeding disorders caused by diseases such as hemophilia which leads to defect in blood coagulation is inducing demand for blood coagulants in the market in the Middle East and Africa region. The beneficial properties of blood coagulant drugs or anti-inhibitor coagulant complexes to help regulate blood coagulation for patients suffering from bleeding disorders are fueling the growth of the Middle East and Africa blood coagulants market.

Rise in incidences of major injuries caused due to accidents leading to uncontrollable bleeding and increasing demand for blood thickening medications are likely to propel the growth of the blood coagulants market in the Middle East and Africa region during the forecast period. However, lack of primary health care services, poor healthcare infrastructure and lack of awareness in the underdeveloped areas are acting as major restraints on the growth of the Middle East and Africa blood coagulation market overview during the forecast period.

Regional Analysis:

The Middle East and Africa blood coagulants market is geographically segmented into few major countries such as Saudi Arabia (KSA), United Arab Emirates (UAE), Qatar, Oman, Kuwait, Egypt, and the rest of the Middle East and Africa.

Saudi Arabia accounts for the largest share in the Middle East and Africa blood coagulant market. The high prevalence of hemophilia, increasing usage of expensive recombinant coagulation factors and high disposable income of the population, are some of the major factors that are driving the growth of the blood coagulant market in this country. Whereas, United Arab Emirates (UAE) is projecting fastest growth in the Middle East and Africa blood coagulants market.

Increasing healthcare expenditure and research and development in the field of anti-inhibitor coagulant complexes are leading to the expansion of the blood coagulants market in the Middle East and Africa region.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Herbal Medicinal Products Market Size, Trends, Growth, and Forecast by 2032

Market Insights

Herbal medicinal products are medicinal products which have been prepared using plant or other natural sources. Herbal plants have a number of medically relevant natural ingredients which can be used in the production of dietary supplements, ointments and a variety  of other medical products. Market Research Future has performed a detailed study regarding the growth of the herbal medicinal products market size is anticipated to grow USD 21.01 billion by 2032 at a healthily CAGR of 12.2 % over the assessment period from 2023 to 2032.

Due to urbanization and the adoption of busy lifestyles, chronic diseases and other lifestyle problems are at an all-time high. Consumers are increasingly becoming health conscious and aware regarding various vital ingredients in medicine and food products. As a result, increasing consumer demand has been witnessed for green label products that are largely composed of natural ingredients. Moreover, allopathic medicine famously uses synthetic chemicals and other ingredients which can cause side effects. The growing awareness regarding these ill effects of allopathic medicine is expected to drive the growth of the herbal medicinal products market. Although it is recommended that consumers consult their doctor before consumption of any medically relevant products, herbal medical products are often very safe to take and do not require a prescription. In certain parts of the world, traditional herbal medicine is still embraced, driving consistent demand. Additionally, there is a low processing cost associated with herbal medicinal products which are also expected to boost market growth over the assessment period.

Notably, the market's growth is hindered by the lack of government support for the promotion of herbal medicinal products. The presence of market players who promote herbal medicinal products which are untested and have no medicinal value is also expected to challenge market growth. However, R&D activities regarding herbal ingredients will likely mitigate some challenges and prove the market with room to grow.

Key Players

Young Living Essential Oils LC (U.S.), ARKOPHARMA Laboratories Company Ltd. (France), Nature's Answer, Inc. (U.S.), TSUMURA & CO. (Japan), Ricola AG (Switzerland), Bio-Botanica Inc. (U.S.), and Sanofi-Aventis Healthcare Pty Ltd. (Australia) are the more prominent market participants in the global herbal medicinal products market. MRFR has identified and recorded pertinent information regarding these players competitive roles in the market.

Market Segmentation

The global herbal medicinal products market has been segmented on the basis of type, function, form, and region. Types of herbal medicinal products have been segmented into homeopathic medicines, traditional Chinese medicines, aromatherapy medicines, ayurvedic medicines, and others. Ayurvedic medicines possess the largest share of the market, and the segment is followed by Chinese medicine. Ayurvedic formulations are in high demand are often easily approved for distribution by the relevant regulatory authorities. 

Function has been segmented to include  cardiovascular health, general wellness, gut & digestive health, cognitive health, and others. Gut and digestive health is the dominating segment among the mentioned segments. The increasing demand and use of herbal medicinal products for digestive problems are expected to drive the market. Herbal medicines for cardiovascular health have been witnessed to have a growing demand.

Forms of herbal medicinal products have been segmented into syrups, powder, ointments, capsules, tablets, oils, and others. Tablets lead the market and are followed by capsules as they deliver the ideal dosage of herbal medicinal ingredients . Tablets and capsules are also easy to store and carry.

Regional Analysis

MRFR has covered regions such as Asia Pacific, Europe, North America and Rest of the World. Europe leads the market with the largest share and is followed by the Asia Pacific regional market. Europe has been observed to be having the highest consumption and demand for herbal medicinal products. The rising awareness regarding herbal ingredients and the support of relevant government bodies for new product launches will likely be key in the region's growth. Meanwhile, the APAC is growing rapidly due to the high adoption of products which include herbal ingredients. Country-level markets such as India and China are the birthplaces of ayurvedic medicine and Chinese medicine respectively. As such the region has an affinity toward the adoption of herbal medicinal products over allopathic medicinal products.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Dental Chair Market Size is forecasted to grow by 2032

Market Overview:

The Dental Chair Market Size is expected to reach USD 1.12 Billion by 2032 at 5.5% CAGR during the forecast period 2023-2032. The two most significant aspects to consider when designing a dental chair are the patient's convenience during dental operations and the dentist's ease while conducting dental treatment, particularly dental surgery. Presently, there are two types of dental chairs: one that is powered by electricity and another that is powered by a manual or non-powered source.

The global Dental Chair Market Share is witnessing a continual rise. Market growth attributes to growing dental issues and dental practices across the globe. Besides, improvements in the functionality of dental chairs drive the growth of the market. Dental chairs play a causal role in improving the patient experience during dental treatments. Increased patient comfort during performing dental procedures and dental surgeries act as a significant growth driver.

Global Dental Chair Market – Competitive Analysis

The dental chair market appears highly competitive and fragmented due to many well-established players forming a competitive landscape. These players adopt strategic approaches such as mergers & acquisitions, collaboration, expansion, and technology launch to strengthen their market positions. 

They invest substantially in developing new technologies and upgrade their existing manufacturing techniques. Also, they make substantial investments to expand their global footprints. They continuously seek improvement and innovation and try to provide quality dental chairs and superior service to their clients, creating service-driven and trusted relationships traders and suppliers.

Major Players:

The Dental Chair Market Players are included.

Dentsply Sirona,

Patterson Dental Supply, Inc.,

PLANMECA OY,

Henry Schein, Inc.,

A-dec Inc.,

Danaher Corporation,

Craftmaster Contour Equipment, Inc.,

Midmark,

KaVo Dental GmbH, and

XO CARE A/S, among others. 

Global Dental Chair Market – Segmentation

The report is Dental Chair Market Segment into four dynamics;

·         By Product: Powered Dental Chairs and Non-Powered Dental Chairs.

·         By Type : Fixed Dental Chair and Portable Dental Chair.

·         By Application: Examination, Oral Surgery, Orthodontics, and others.

·         By Regions:  North America, Europe, APAC, and Rest of the World.

Moreover, surging demand for dental aesthetic treatments and dental procedures escalate market growth. According to Market Research Future (MRFR), the global dental chair market outlook is expected to reach a valuation of USD 627.1 MN by 2030, registering 4.1% CAGR over the assessment period (2022 – 2030). The spurting rise in the number of dental examinations and procedures performed worldwide, create huge market demand.

Dental Chair Market – Regional Analysis

North America leads the global dental chair market, heading with the increasing numbers of dentists and dental treatment procedures in the region. Also, factors such as the strong presence of major industry players and well-equipped dental care centers drive regional market growth. Besides, increasing R&D activities carried with substantial investments for the development of innovative products boosts the growth of the regional market.

Additionally, the increasing demand for prosthodontics and raising awareness about oral health push the growth of the regional market. Furthermore, the high expenditures on oral care, increasing demand for better dental care infrastructures, and rapid uptake of new technologies in the manufacturing substantiate the regional market growth. The dental chair market in North America is projected to retain its dominance over the global market throughout the review period.

Europe holds the second-leading position in the global dental chair market due to the well-established dentistry in the region. Moreover, factors such as the strong presence of key dental chair manufacturers and the increasing number of dental practices propel the regional market growth. Rise in numbers of dentists creates a high demand for dental equipment, including the dental chair. Besides, rising cases of root canal procedures and oral & dental surgeries boost the growth of the regional market. The dental chair market in Europe is expected to create a substantial revenue pocket.

The Asia Pacific dental chair market is growing rapidly. Factors such as the augmenting demand for dental procedures and rising numbers of dental care providers in the region foster market growth. Moreover, increasing per capita healthcare expenses and developing healthcare infrastructure drive the regional market growth excellently. Besides, the proliferation of oral health insurance propels the growth of the regional market. Additionally, the rapidly growing population, healthcare sectors, and the growing focus on improving the healthcare facilities contribute to the regional market growth.

Related reports-

Robot-Assisted Surgical Systems Market

3D Printing Medical Devices Market

Pacemaker Market

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Corneal Transplant Market Size, Strategies & Key Players Review by Forecast to 2032

Global Corneal Transplant Market   - Overview

Accrediting the kind of growth, the market is witnessing and the growth prospect the market is demonstrating, Market Research Future (MRFR), has recently published a brilliant study report. According to MRFR, the Global Corneal Transplant market size is expected to perceive exponential growth 11.20% CAGR during the forecasted period (2023 -2032).

The global Corneal Transplant Market insights is growing pervasively over last decade. Factors such as increasing prevalence injuries & diseases related to the eye/ sight that fuel the transplants cases are fuelling the market growth to an extent. Also the risk factors for the blindness & eye sight disorders are creating the demand for the better Corneal Transplants and treatment methods in turn, speed up the market growth.

Other factors propelling the market growth include the changing lifestyle owing to the growing urbanization & industrialization coupled with the growing economic conditions that enable access to the quality life & to the improved healthcare worldwide. Advancements in surgeries, fuel the market growth. In addition, factors such as increasing number of surgeries and rising demand for new techniques for the treatment provide major impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with Corneal Transplant and the differential awareness and availability between developing and the developed world are posing challenges to the market growth. Nevertheless, new products and services offered to the developing countries and emerging economies by the well-established market players in the developed countries are filling up this gap. This will resultantly foster the market growth.

Global Corneal Transplant Market   - Competitive Analysis

Global Corneal Transplant market players are

Florida Lions Eye Bank

CorNeat Vision

CorneaGen

San Diego Eye Bank

Alabama Eye Bank

Aurolab

Cornea Biosciences

KERAMED INC.

Price Vision Group

0 LinkoCare LifeSciences AB

Presbia PLC

AJL Ophthalmic SA

DIOPTER

Massachusetts Eye and Ear

The global Corneal Transplant market is a fragmented market with a large number of players. Product development strategy has been curtailed by the excellent efficiency and efficacy of drugs. However, the rise of drug resistance has opened doors for new drug development and is an opportunity for a new market leader. The rise of spurious and counterfeit medicines have reduced the total market revenues and at the same time displaced standard drugs off the market.

Global Corneal Transplant Market      - Segments

For an easy grasp and enhanced understanding, the report - Global Corneal Transplant Market is segmented in to 4 Key dynamics;

By Surgery Types        : Comprises - Penetrating Keratoplasty, DSAEK (Descemet Stripping Automated Endothelial Keratoplasty), Endothelial Keratoplasty, Corneal Graft, and Corneal Limbal Stem Cell Transplant among others.

By Indications             : Bullous Keratopathy, Fungal Corneal Ulcer, Keratoconus, Corneal Stromal Dystrophies, and Keratitis among others.

By End Users               : Hospitals & Eye clinics among others.

By Regions                  :  North America, Europe, APAC and Rest of the World.

Global Corneal Transplant Market   - Regional Analysis

Globally, Europe is the largest market for the Corneal Transplant. Factors such as the availability of multiple treatment options, prevention strategy as well as rising influence of organ donation programs, coupled with the increased government emphasis on organ donation policies drive the regional growth of the market. Moreover, increasing prevalence of diabetes in the region are providing impetus to the market growth.

While North America region stands as the second-largest market for Corneal Transplant. This growth attributes to the increasing demand for corneal transplant surgery coupled with the growing prevalence of eye diseases, and vision impairment among people in the region drive the regional market growth. Moreover, growing Centers for Disease Control and Prevention, coupled with the age-related eye diseases such as age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma are leading causes of blindness and vision imparity especially in the United States; such factors foster the regional market growth.

On the other hand the developing regions markets particularly Asia Pacific will be the fastest growing market for Corneal Transplant. Risk factors for the eye diseases such as the ever-increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity provide impetus to the growth of the regional market. Attributing to the availability of qualitative eye care treatment and skilled medical professionals, India has become one of the international medical tourism destinations across the world. This, in turn fuels the growth of corneal transplant market in India resultantly, fostering the growth of the APAC market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America